{"name":"OncoSil Medical Limited","slug":"oncosil-medical-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FOLFIRINOX chemotherapy","genericName":"FOLFIRINOX chemotherapy","slug":"folfirinox-chemotherapy","indication":"Metastatic pancreatic cancer","status":"phase_2"}]}],"pipeline":[{"name":"FOLFIRINOX chemotherapy","genericName":"FOLFIRINOX chemotherapy","slug":"folfirinox-chemotherapy","phase":"phase_2","mechanism":"FOLFIRINOX is a chemotherapy regimen that combines four different drugs to target rapidly dividing cancer cells.","indications":["Metastatic pancreatic cancer","Locally advanced pancreatic cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNR0twSHktVk9leUVGV0wyVHBycDh6VjFabXRJQnhQSkNzamJOWjBoSFVmSHltYUpTcXV0dXJ6TEhtVFNhdlNIMGwwYlBmbFFtT1FBX1lkV1VuTWVqQ3ZXMjZKaXJ3V1Y0TXdwMk5kWU0ya0Z3RlNPTUN2MVN4akVSRVgyTFBPdERVN0tBc3B3Wk52MEx1aGZvTU9tVVNOanBwZUtjNDFmVXJ4OG1uT1R4bnd3djFERXB2WVdZ?oc=5","date":"2025-05-26","type":"pipeline","source":"forbes.com.au","summary":"Australian startups take on big pharma with precision cancer breakthroughs - forbes.com.au","headline":"Australian startups take on big pharma with precision cancer breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNeUxta1NYekZYaDBFLXdWazl5SzRocHNNWmJrQlBhdDdoUlVXb1lIc2FwWDJyaFAtRks2bkFPRTdncldQenhmc0MxTXIzLTlrbW9nLU8zTWlkZm1qSVFmXzlmRHhkRU9BSmNoQ2tQU3gxd29kSVQ3ZXJVNGpqQkNWc1V0SHhOd2NpYXFLRm5kZ2twWXAzRl9US3ZMZW9oajNqTnBZU2ZWNVFNbUxESGI5R3BQeF9UdlViSVVRTms2MGRwa2hiR001a1UyZ0VnUjY2?oc=5","date":"2025-05-07","type":"pipeline","source":"Stockhead","summary":"Health Check: It’s sale time as Medadvisor mulls Aussie exit and Althea renounces medicinal cannabis - Stockhead","headline":"Health Check: It’s sale time as Medadvisor mulls Aussie exit and Althea renounces medicinal cannabis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFA4bkh3YUJvUzJxU2dfSDhRZmszVl9nSHZwOC1aSnRjZEF5Ni1uaFBCN2JWNTN6X0ZzdGNObG81Y3psNFRNVVdOa2xSQjlsZWtkcTNVQ0syQWVyVzU2YnZoeUczYU1nQWNLOXluVHRYUGpwb080?oc=5","date":"2024-04-18","type":"pipeline","source":"proactiveinvestors.ca","summary":"Cann Group Ltd Share Price - CAN, RNS News, Articles, Quotes, & Charts (ASX:CAN) - proactiveinvestors.ca","headline":"Cann Group Ltd Share Price - CAN, RNS News, Articles, Quotes, & Charts (ASX:CAN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxOVTNRajBsdl9rcXdSUFA3cTRmRmxtbUJZblFDUnhSblJaWU9qNi1LeU5LRjk2dkFEWF81bDdjWjhKbWdkWlhwRXdRYjJDMjBFemhialFBbkhQcjVxX2VyajFfSmllMFFYUDUyakV6UHREenhxZTg4X0NUdmdBZm1aYzhlZGI5QjFMS2VnNE4yYlBNX0hKaXBqQUVMNklxb3p3LWlyMU5ZVmE5QUFaclMycS00cFFVb0duZDIycm9fMGpjN19GYVEtYTFnS2RiQWxoWkU4R3VjLW91QjBjZEFfd3AtSmwzVElmTlZMbGZmeFk5Z3dRX2ltSDVVb0ptakVkMUZhRVc2eTd3QQ?oc=5","date":"2023-06-05","type":"pipeline","source":"The Mercury","summary":"ASX Health Stocks: OncoSil’s cancer fight takes big step - The Mercury","headline":"ASX Health Stocks: OncoSil’s cancer fight takes big step","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9KTm1LYWg3d2hMVGwwdmdVLTJrQ09pSFc5d1VPQXB3YTcxTGhVWDU2Vk53RE5MQ3dGd2JmN21ISFl6V0RqUW1HUnBPMjVUak14RExJLU04NWg5TkJ1MzBqaW1BZWEtRTg?oc=5","date":"2021-03-25","type":"pipeline","source":"Proactive financial news","summary":"Opthea Ltd Share Price - OPT, RNS News, Articles, Quotes, & Charts (ASX:OPT) - Proactive financial news","headline":"Opthea Ltd Share Price - OPT, RNS News, Articles, Quotes, & Charts (ASX:OPT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1sdkFCVGpacmJjYVRwRHVWTWxPa3ZvR3M3c3J4c0N6U0lkU1g1RkJvYnVTYnJNWHY5SzY0TEdEeUxtb1ZsYUtSWU1mdkNiOGJwbU5BMEl6c0JnQ3pRWFpPS3Y3LXIxTHZF?oc=5","date":"2019-12-26","type":"pipeline","source":"Proactive financial news","summary":"Dimerix Ltd Share Price - DXB, RNS News, Articles, Quotes, & Charts (ASX:DXB) - Proactive financial news","headline":"Dimerix Ltd Share Price - DXB, RNS News, Articles, Quotes, & Charts (ASX:DXB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE03QXdSbmVIaV9FVnBUQUZsV2FwMFRRRFJIUXlOQXNFSmNLc3h6LVl3MzVTdl9YZ0pTOGtJZVkzOUo5dUpqUk1nd1lKX2NhNThubF9DaTM4Z3hyT3NoSE5CUg?oc=5","date":"2018-06-05","type":"pipeline","source":"businessnews.com.au","summary":"Daniel Kenny - businessnews.com.au","headline":"Daniel Kenny","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxObE1sM2x5c3ZjaVpZUGkyTnNXNzl2T0lYWnJfZXY2MEJFZHJBaTJHV0psS1BRUnMwblQ3MjcxbUlhRzdMcV9YcTF6azNpQUg4ckJiQVliREY4Uzd4RTNpbEZ1M1RaLXBuMDJDUk9fSktfcU84eS1Hekx0bjhiY3RtTmdfVFYteFJraDhIWlVNbE8wY3U1RUdzMGlPbkxRZ0FNNEZRU3RQZWRudFBxUUVXWkNDZWJ2QzhyMmVVWmkzRF9US3JyelF3?oc=5","date":"2016-09-26","type":"pipeline","source":"Proactive financial news","summary":"OncoSil Medical Ltd swells cash position after tax refund - Proactive financial news","headline":"OncoSil Medical Ltd swells cash position after tax refund","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNT2ZOSmRGa0tST2ZHVU01QnpZSkhfYmVvWVFVRUptdzJhRWlqOVN2bGhaOFM0ajhZZ3IzUndfSEllVmVsWGo3VlJacTRUb2RLMjc1RUdFQTlCQ1VYUk5TMFprQzUwTnhVQl9MMHlFdzk5UXRIS19hU0c5LVF3WE55d3dZM0YtMDB2M3YzN3VkYXltV3IzbW9Od2lKM0JBUnlsQjduRHIxSUFib1ZEbHYwUVozaGdFS1JiUUxLVkl2anEyd2hLODVPeEZGZmFxb3NP?oc=5","date":"2014-07-16","type":"pipeline","source":"Proactive financial news","summary":"OncoSil Medical finalises manufacturing for pancreatic cancer device - Proactive financial news","headline":"OncoSil Medical finalises manufacturing for pancreatic cancer device","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQZWpEZWNadlNhaVJ0dE92SE9TOHdlVmFSQkctZFJEM0pFY2lVd2tvTUJ6TUdrUExqb1VfTUwtLUZXbEFPUHFxeEh5QlY0R1JaN2tFbFlob255NnhTbXZyd1lKR2Jwd3l5UXowZ2ljLXpnOHFfLThkLTFXZkw4ZFlEeWxoSGVidWtQWXQtMEQydHV4U0JuZWJ1V0UwX0ZkY1lLSkNhY2hsMjd4b1RnOTRYa3VtZnVRV2w1eE0xYUpXVDRGUGRxTk1VMDlwWEUtdEotYVVPVWY3RlI?oc=5","date":"2014-01-16","type":"regulatory","source":"Proactive financial news","summary":"OncoSil Medical completes U.S. FDA gap analysis for pancreatic cancer device - Proactive financial news","headline":"OncoSil Medical completes U.S. FDA gap analysis for pancreatic cancer device","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}